Company news
Vera Therapeutics, Inc. (NASDAQ:VERA) news
Vera Therapeutics, Inc. news releases on 6ix. Latest, May 3, 2022: Vera Therapeutics Announces Two Oral Presentations at the 59th European Renal Association…
Press releases — page 3
Vera Therapeutics Announces Two Oral Presentations at the 59th European Renal Association – European Dialysis and Transplant Association Congress Featuring New Clinical Data on Atacicept in IgA Nephropathy and in Systemic Lupus Erythematosus
May 2, 2022
Vera Therapeutics Selected to Present Interim Phase 2 Data for MAU868 to Treat BK Virus in Kidney Transplant Patients as Oral Late-Breaker at the American Transplant Congress 2022
May 1, 2022
Vera Therapeutics Announces Appointment of Michael M. Morrissey, Ph.D., as Chairman of its Board of Directors
April 11, 2022
Vera Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
March 23, 2022
Vera Therapeutics to Host BK Virus Webinar Featuring Stanley C. Jordan, M.D., World-Renowned Transplant Nephrologist and Pioneering Kidney Transplant Researcher
March 20, 2022
Vera Therapeutics to Host Business Update Call
March 16, 2022
Vera Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference
February 28, 2022
Vera Therapeutics Announces Closing of Upsized Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 13, 2022
Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis
January 17, 2022
Vera Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 3, 2022
Vera Therapeutics Announces Acquisition of Monoclonal Antibody From Pfizer to Treat BK Virus in Transplant Patients
December 16, 2021
Vera Therapeutics Announces Appointment of Kimball Hall to Board of Directors
December 13, 2021
Vera Therapeutics to Present at Upcoming Investment Conferences in November 2021
November 9, 2021
Vera Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 9, 2021
Vera Therapeutics Presents Phase 2a Data Showing Atacicept Reduces Serum Gd-IgA1 in Patients with IgA Nephropathy at the American Society of Nephrology Kidney Week 2021
November 3, 2021
Vera Therapeutics to Present Phase 2a Data on Atacicept in IgA Nephropathy at the American Society of Nephrology Kidney Week 2021 Annual Meeting
October 12, 2021
Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephropathy
September 8, 2021
Vera Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 15, 2021
Vera Therapeutics Appoints Sean Grant as Chief Financial Officer
July 13, 2021
Vera Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
June 23, 2021
Vera Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
May 26, 2021
Vera Therapeutics Announces Pricing of Initial Public Offering
May 12, 2021